Medline (MDLN) Stock Forecast & Price Target
Score
Medline Inc. price target
| MDLN | |
|---|---|
| Low | $37.00 |
| Average | $44.20 |
| High | $55.00 |
| Upside vs current price | +17.3% |
The average target of $44.20 is +17.3% versus the current MDLN price of $37.68.
Medline Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 7 |
| Buy | 16 |
| Hold | 4 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
27 analysts cover MDLN.
Medline Inc. EPS and revenue estimates
Published annual figures for MDLN on this page are 2026 EPS $1.49, 2027 EPS $1.56. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $1.49 | $31.23B |
| 2027 | $1.56 | $33.69B |
Is Medline Inc. a buy or sell?
Of the 27 analysts covering Medline Inc., 23 rate it a buy (7 strong buy and 16 buy), 4 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The MDLN consensus label is Buy, beside 23 buy-side ratings and 0 sell-side ratings.
The average target of $44.20 implies +17.3% versus the current price of $37.68.
The MDLN rating block is 27 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the Medline Inc. forecast
A wide spread is the story on MDLN. Targets run from $37.00 to $55.00, with $44.20 as the average.
The gap from the $37.68 price to the MDLN average is +17.3%.
The MDLN rating mix is lopsided rather than split: 23 of 27 analysts are on the buy side, 4 are at hold, and 0 are on the sell side, and the published consensus is Buy.
MDLN targets have not moved much: $44.00 recently, $44.20 across the quarter.
the Medline Inc. is followed by 27 analysts, so the range matters more than any one target.
Medline Inc. forecast questions
What is the MDLN price target?
The published range for MDLN is $37.00 to $55.00, with an average of $44.20. That average is +17.3% versus the current price of $37.68.
Is Medline Inc. a buy or sell?
Of the 27 analysts covering Medline Inc., 23 rate it a buy, 4 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving MDLN at 23 buy ratings, 4 holds, and 0 sells.
What is the EPS estimate for Medline Inc.?
Analyst EPS estimates for Medline Inc.: 2026 $1.49, 2027 $1.56.
What is the revenue estimate for Medline Inc.?
Analyst revenue estimates for Medline Inc.: 2026 $31.23B, 2027 $33.69B.
How many analysts cover MDLN?
27 analysts cover MDLN. Their consensus on MDLN is Buy, across those 27.